#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma stage I Superficial vein thrombosis Uterine leiomyosarcoma Primary amyloidosis Hypochondroplasia Cutaneous T-cell lymphoma refractory Thrombotic microangiopathy Infection in an immunocompromised host Transferrin decreased Adenocarcinoma pancreas Frontotemporal dementia Obesity Immune-mediated renal disorder Anal fistula Liposarcoma recurrent More trials…

    Learn about Rare Diseases

    Mucous membrane pemphigoid – Trials in Disease Haemophilia A without inhibitors Haemophilia B without inhibitors – Treatment Gastrointestinal stromal tumour – Treatment Primary hyperoxaluria – Treatment Familial haemophagocytic lymphohistiocytosis – Trials in Disease Friedreich’s ataxia – Treatment Usher’s syndrome – Trials in Disease Mucopolysaccharidosis III – Diagnostics Erdheim-Chester disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Permethrin Agomelatine M-(18F)-Fluorobenzylguanidine Acetazolamide Esk-001 Alclometasone Dipropionate Clindamycin Phosphate Trabectedin Clomipramine Hydrochloride APAZUNERSEN MB-HUCART19.1 Betula Pendula Pollen Extract Danicopan Pregabalin NALMEFENE HYDROCHLORIDE [14C]ZIPALERTINIB Oxogluric Acid Fludarabine Phosphate Ph. Eur. Amg 193 AGANIRSEN More therapies…

    Learn about Your Condition

    Mitral valve disease Pelvic venous thrombosis Diverticulitis Aortic aneurysm Cutaneous lupus erythematosus Hepatotoxicity Colorectal cancer metastatic Mantle cell lymphoma stage III Colitis Bronchostenosis Peritoneal abscess BRAF gene mutation Osteoporosis Papulopustular rosacea Pulmonary vascular disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Three‑Day versus Seven‑Day Antibiotic Treatment with doxycycline, amoxicillin and ceftriaxone in adults with mild leptospirosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Amoxicillin
    • Ceftriaxone
    • Doxycycline Hyclate
    France

  • Study of Camizestrant plus Ribociclib as First‑Line Treatment for Patients with ER‑Positive, HER2‑Negative Advanced Breast Cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Camizestrant
    • Ribociclib
    France Germany Italy Poland Spain

  • Randomized Placebo‑Controlled Trial of Colchicine to Slow Disease Progression in Adults with Amyotrophic Lateral Sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • Colchicine
    Italy

  • Phase II Study of Lutetium (177Lu) Zadavotide Guraxetan Radioligand Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Lutetium (177Lu) Zadavotide Guraxetan
    Sweden

  • Efficacy and Safety of Berotralstat for Preventing Angioedema Attacks in Patients with Acquired Angioedema due to C1 Inhibitor Deficiency

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Berotralstat
    Italy

  • Assessing the prognostic value of PSMA‑T4 SPECT/CT imaging in patients with triple‑negative breast cancer undergoing neoadjuvant therapy

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Poland
Previous Page
1 … 664 665 666 667 668 … 1,655
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!